Page last updated: 2024-11-05

azetepa

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID31321
CHEMBL ID474928
CHEBI ID177509
SCHEMBL ID4557
MeSH IDM0085636

Synonyms (32)

Synonym
n-[bis(aziridin-1-yl)phosphoryl]-n-ethyl-1,3,4-thiadiazol-2-amine
CHEBI:177509
azetepa (usan/inn)
D03036
125-45-1
azetepa
nsc-64826
azatep
thiatriamide
aza tepa
phosphinic amide,p-bis(1-aziridinyl)-n-ethyl-n-(1,3,4-thiadiazol-2-yl)-
phosphinic amide,p-bis(1-aziridinyl)-n-ethyl-n-1,3,4-thiadiazol-2-yl-
p,3,4-thiadiazol-2-ylphosphinic amide
cl 25477
azatepa
nsc64826
cl-25477
CHEMBL474928
nsc 64826
azetepa [usan]
phosphinic amide, p,p-bis(1-aziridinyl)-n-ethyl-n-1,3,4-thiadiazol-2-yl-
p,p-bis(1-aziridinyl)-n-ethyl-n-1,3,4-thiadiazol-2-ylphosphinic amide
d57i4z650l ,
azatepum
azatepum [inn-latin]
unii-d57i4z650l
azatepa [inn]
azatepa [who-dd]
SCHEMBL4557
DTXSID10154543
azatep; cl 25477; nsc-64826
Q27276113
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phosphoramideA compound in which one or more of the OH groups of phosphoric acid have been replaced with an amino or substituted amino group. The term is commonly confined to the phosphoric triamides, P(=O)(NR2)3, since replacement of one or two OH groups produces phosphoramidic acids: P(=O)(OH)(NR2)2 , P(=O)(OH)2(NR2).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID409956Inhibition of mouse brain MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.34 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]